Sam Altman's Psychedelic Breakthrough: How The OpenAI Visionary Plans To Transform Mental Health Care With MDMA
Sam Altman, co-founder of OpenAI, is backing psychedelic treatments like MDMA through Journey Colab to revolutionize mental health care after his own transformative experiences
